These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 22431509)

  • 41. Polycomb group protein-associated chromatin is reproduced in post-mitotic G1 phase and is required for S phase progression.
    Aoto T; Saitoh N; Sakamoto Y; Watanabe S; Nakao M
    J Biol Chem; 2008 Jul; 283(27):18905-15. PubMed ID: 18453536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Environmental estrogens differentially engage the histone methyltransferase EZH2 to increase risk of uterine tumorigenesis.
    Greathouse KL; Bredfeldt T; Everitt JI; Lin K; Berry T; Kannan K; Mittelstadt ML; Ho SM; Walker CL
    Mol Cancer Res; 2012 Apr; 10(4):546-57. PubMed ID: 22504913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Global gene expression analysis of very small embryonic-like stem cells reveals that the Ezh2-dependent bivalent domain mechanism contributes to their pluripotent state.
    Shin DM; Liu R; Wu W; Waigel SJ; Zacharias W; Ratajczak MZ; Kucia M
    Stem Cells Dev; 2012 Jul; 21(10):1639-52. PubMed ID: 22023227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of CD11b transcription by decreasing PRC2 and increased acH4 level during ATRA-induced HL-60 differentiation.
    Tang H; Chen F; Tan Q; Tan S; Liu L; Zhang F
    Acta Biochim Biophys Sin (Shanghai); 2009 Jul; 41(7):588-93. PubMed ID: 19578722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence.
    Agherbi H; Gaussmann-Wenger A; Verthuy C; Chasson L; Serrano M; Djabali M
    PLoS One; 2009 May; 4(5):e5622. PubMed ID: 19462008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional characterization of human Polycomb-like 3 isoforms identifies them as components of distinct EZH2 protein complexes.
    Boulay G; Rosnoblet C; Guérardel C; Angrand PO; Leprince D
    Biochem J; 2011 Mar; 434(2):333-42. PubMed ID: 21143197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
    Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A model for transmission of the H3K27me3 epigenetic mark.
    Hansen KH; Bracken AP; Pasini D; Dietrich N; Gehani SS; Monrad A; Rappsilber J; Lerdrup M; Helin K
    Nat Cell Biol; 2008 Nov; 10(11):1291-300. PubMed ID: 18931660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PRC2 directly methylates GATA4 and represses its transcriptional activity.
    He A; Shen X; Ma Q; Cao J; von Gise A; Zhou P; Wang G; Marquez VE; Orkin SH; Pu WT
    Genes Dev; 2012 Jan; 26(1):37-42. PubMed ID: 22215809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex.
    Duan Z; Zou JX; Yang P; Wang Y; Borowsky AD; Gao AC; Chen HW
    Prostate; 2013 Apr; 73(5):455-66. PubMed ID: 23038103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation.
    Caretti G; Di Padova M; Micales B; Lyons GE; Sartorelli V
    Genes Dev; 2004 Nov; 18(21):2627-38. PubMed ID: 15520282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair.
    Ezhkova E; Lien WH; Stokes N; Pasolli HA; Silva JM; Fuchs E
    Genes Dev; 2011 Mar; 25(5):485-98. PubMed ID: 21317239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polycomb recruitment at the Class II transactivator gene.
    Boyd NH; Morgan JE; Greer SF
    Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of BAP1 function leads to EZH2-dependent transformation.
    LaFave LM; Béguelin W; Koche R; Teater M; Spitzer B; Chramiec A; Papalexi E; Keller MD; Hricik T; Konstantinoff K; Micol JB; Durham B; Knutson SK; Campbell JE; Blum G; Shi X; Doud EH; Krivtsov AV; Chung YR; Khodos I; de Stanchina E; Ouerfelli O; Adusumilli PS; Thomas PM; Kelleher NL; Luo M; Keilhack H; Abdel-Wahab O; Melnick A; Armstrong SA; Levine RL
    Nat Med; 2015 Nov; 21(11):1344-9. PubMed ID: 26437366
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies.
    Puda A; Milosevic JD; Berg T; Klampfl T; Harutyunyan AS; Gisslinger B; Rumi E; Pietra D; Malcovati L; Elena C; Doubek M; Steurer M; Tosic N; Pavlovic S; Guglielmelli P; Pieri L; Vannucchi AM; Gisslinger H; Cazzola M; Kralovics R
    Am J Hematol; 2012 Mar; 87(3):245-50. PubMed ID: 22190018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.
    Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J
    Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas.
    Sneeringer CJ; Scott MP; Kuntz KW; Knutson SK; Pollock RM; Richon VM; Copeland RA
    Proc Natl Acad Sci U S A; 2010 Dec; 107(49):20980-5. PubMed ID: 21078963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polycomb group protein enhancer of zeste 2 is an oncogene that promotes the neoplastic transformation of a benign prostatic epithelial cell line.
    Karanikolas BD; Figueiredo ML; Wu L
    Mol Cancer Res; 2009 Sep; 7(9):1456-65. PubMed ID: 19723877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The downregulation of GFI1 by the EZH2-NDY1/KDM2B-JARID2 axis and by human cytomegalovirus (HCMV) associated factors allows the activation of the HCMV major IE promoter and the transition to productive infection.
    Sourvinos G; Morou A; Sanidas I; Codruta I; Ezell SA; Doxaki C; Kampranis SC; Kottakis F; Tsichlis PN
    PLoS Pathog; 2014 May; 10(5):e1004136. PubMed ID: 24830456
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polycomb repressor complex-2 is a novel target for mesothelioma therapy.
    Kemp CD; Rao M; Xi S; Inchauste S; Mani H; Fetsch P; Filie A; Zhang M; Hong JA; Walker RL; Zhu YJ; Ripley RT; Mathur A; Liu F; Yang M; Meltzer PA; Marquez VE; De Rienzo A; Bueno R; Schrump DS
    Clin Cancer Res; 2012 Jan; 18(1):77-90. PubMed ID: 22028491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.